We therefore performed a prospective , randomized trial comparing the effects of standard ( achieve LDL-C levels recommended by the Japanese guidelines ) and intensive ( achieve 30 % lower LDL-C levels than standard ) rosuvastatin therapy for 1 year in 60 hypercholesterolemic patients with a primary endpoint of aortic atherosclerotic plaques evaluated by non-invasive magnetic resonance imaging ( MRI ) .